Although a limited future time perspective (FTP) has been theorized to be the underlying mechanism of positive emotional functioning later in life, there is scant empirical evidence for this position. Using an integrative data-analytic approach, we investigated the predictive value of FTP, age, and subjective health in explaining emotional functioning in a sample of 2,504 adults (17 to 87 years, M = 35.5, SD = 14.2). Although older adults reported a more limited FTP than younger adults, age and a limited FTP had opposite effects in predicting subjective well-being, affect, positive emotions, empathy, and attitudes toward emotions. That is, old age was linked to a more adaptive emotional profile, whereas a limited FTP was linked to a more maladaptive emotional profile. This was the case even after controlling for health-related aspects. The findings question the usage of FTP as an explanatory variable for observed age differences in emotional functioning. (PsycINFO Database Record

cleaved caspase-3, were assessed by immunohistochemical staining. The inhibitory effects of SAC on prostate cancer invasion was examined by immunoreactivity of Ecadherin and its binding proteins α , β and γ -catenins. The serum prostate-specific antigen (PSA) level at three different times (initiation, middle and end of treatment) and toxicity of SAC on several organs after treatment were assessed. RESULTSTreatment with SAC resulted in inhibition of the growth of CWR22R, with no detectable toxic effect on nude mice. The SAC-induced growth reduction was correlated with a concurrent reduction in serum PSA level and proliferation rate of xenografts, together with an inhibition of invasion through the restoration of E-cadherin and γ -catenin expression. Furthermore, the apoptotic rate of SAC-treated tumours increased together with a decrease in Bcl-2 and increase in cleaved caspase-3. CONCLUSIONThese results suggest that this garlic-derived compound might be a potential therapeutic agent for suppressing AI prostate cancer.

No abstract

The correlations between microbiota dysbiosis and cancer have gained extensive attention and been widely explored. As a leading cancer diagnosis worldwide, lung cancer poses a great threat to human health. The healthy human lungs are consistently exposed to external environment and harbor a specific pattern of microbiota, sharing many key pathological and physiological characteristics with the intestinal tract. Although previous findings uncovered the critical roles of microbiota in tumorigenesis and response to anticancer therapy, most of them were focused on the intestinal microbiota rather than lung microbiota. Notably, the considerable functions of microbiota in maintaining lung homeostasis should not be neglected as the microbiome dysbiosis may promote tumor development and progression through production of cytokines and toxins and multiple other pathways. Despite the fact that increasing studies have revealed the effect of microbiome on the induction of lung cancer and different disease status, the underlying mechanisms and potential therapeutic strategies remained unclear. Herein, we summarized the recent progresses about microbiome in lung cancer and further discussed the role of microbial communities in promoting lung cancer progression and the current status of therapeutic approaches targeting microbiome to alleviate and even cure lung cancer.